FDA Warning Letter — Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Case 417081 — FEI 3003744377

The FDA took a Warning Letter action against Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on July 9, 2014 (Taizhou, China). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Date
July 9, 2014
Fiscal Year
2014
Product Type
Drugs
Center
CDER
Location
Taizhou (China)